Wanda Phipatanakul is a Rheumatology/Immunology physician affiliated with Boston Children's Hospital. OpenAlex indexes 689 publications with 17,208 citations (h-index 67); ClinicalTrials.gov lists 10 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Allergy & Immunology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Longwood Ave
Boston, MA 021155724
Telephone
617-355-6117Registry record last updated 8 Jul 2007.
Clinical trials
- Radon Asthma Intervention Trial
Sponsor: Boston Children's Hospital
- Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy
Sponsor: Boston Children's Hospital
- Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism
Sponsor: Boston Children's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202523 payments$56,306openpaymentsdata.cms.gov ↗
- Regeneron Healthcare Solutions, Inc.Program year202537 payments$37,073openpaymentsdata.cms.gov ↗
- Genentech USA, Inc.Program year202519 payments$19,018openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
13 NIH research awards on record, funded 2003–2026 per NIH RePORTER. The latest:
- Controlling and Preventing Asthma Progression and Severity in Kids with Omalizumab Extension (PARK-EXT)
Boston Children'S Hospital
FY2026$2,250,000U01AI179563 - Novel NOTCH4 Pathway of Asthma Severity in Urban School Children: Clinical Research Center, Boston Children’s Hospital
Boston Children'S Hospital
FY2026$759,000U01AI160087 - Genetic and microbial modifiers of Atopic Dermatitis (AD): Mechanisms of increased AD severity in patients with the R576 polymorphism in IL-4Ra and impact of S aureus skin decolonization on AD
Boston Children'S Hospital
FY2026$525,764U01AI152033
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mucus Plugs Persist in Asthma, and Changes in Mucus Plugs Associate with Changes in Airflow over Time
American Journal of Respiratory and Critical Care Medicine
2022 - Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions
Annals of Allergy Asthma & Immunology
2022 - Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect
The Journal of Allergy and Clinical Immunology In Practice
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Stuart Orkin, MD
Boston Children's Hospital
Jane Newburger, MD
Boston Children's Hospital
Michael Landzberg, MD
Boston Children's Hospital
Stephen Sallan, MD
Boston Children's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”